Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia
Investegate announcements from atai Life Sciences, atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia
Source: investegate.co.uk